CUSIP: 87164U201
Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
8,450,888
-
Share change
-
+6,607,538
-
Total reported value
-
$5,763,098
-
Price per share
-
$0.68
-
Number of holders
-
19
-
Value change
-
+$4,905,975
-
Number of buys
-
18
-
Number of sells
-
4
Quarterly Holders Quick Answers
What is CUSIP 87164U201?
CUSIP 87164U201 identifies SYN - THERIVA BIOLOGICS INC COM NEW - Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2021
-
Previous quarter:
Q4 2020
Recent filing periods for CUSIP 87164U201:
Institutional Holders of THERIVA BIOLOGICS INC COM NEW - Stock (SYN) as of Q1 2021
As of 31 Mar 2021,
THERIVA BIOLOGICS INC COM NEW - Stock (SYN) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,450,888 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, MSD Partners, L.P., GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, CITADEL ADVISORS LLC, Virtu Financial LLC, NORTHERN TRUST CORP, Fisher Asset Management, LLC, and BRIDGEWAY CAPITAL MANAGEMENT, LLC.
This page lists
19
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.